Dr. Seoan Huh Amgen Inc., USA

Dr. Seoan Huh is a regulatory affairs expert with extensive experience in the development of innovative therapeutics, including gene therapies, gene editing technologies, and treatments for rare diseases. Her work focuses on bridging scientific innovation and regulatory strategy to support the advancement of novel therapies from early development through clinical... read moretranslation. Dr. Huh has a multidisciplinary background spanning neuroscience, biomedical research, entrepreneurship, and regulatory science, enabling her to approach therapeutic development from both scientific and strategic perspectives. Her expertise includes regulatory considerations for advanced therapies, clinical development strategies, long-term follow-up of gene therapy trial participants, and approaches for translating emerging technologies into patient-focused solutions. She has contributed to publications on gene therapy development and regulatory science. Dr. Huh is passionate about advancing translational medicine by connecting research discoveries with effective regulatory pathways and helping accelerate the development of innovative therapies for patients with unmet medical needs.